ECSP099328A - Análogos de pirazol - Google Patents

Análogos de pirazol

Info

Publication number
ECSP099328A
ECSP099328A EC2009009328A ECSP099328A ECSP099328A EC SP099328 A ECSP099328 A EC SP099328A EC 2009009328 A EC2009009328 A EC 2009009328A EC SP099328 A ECSP099328 A EC SP099328A EC SP099328 A ECSP099328 A EC SP099328A
Authority
EC
Ecuador
Prior art keywords
compounds
pirazol
analogs
disorders
preparation
Prior art date
Application number
EC2009009328A
Other languages
English (en)
Inventor
Todd Michael Maddux
Matthew J Graneto
Jaime L Masferrer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ECSP099328A publication Critical patent/ECSP099328A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a compuestos de fórmula (I) (consta gráfico) o una sal y solvato farmacéuticamente aceptables del mismo, en la que R1 es F o H y a procedimientos para su preparación, a intermedios utilizados en su preparación, a composiciones que los contienen dichos compuestos. Los compuestos según la presente invención son útiles en numerosas enfermedades, trastornos y afecciones, en particular enfermedades, trastornos y afecciones alérgicas y respiratorias.
EC2009009328A 2006-11-27 2009-05-13 Análogos de pirazol ECSP099328A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86733706P 2006-11-27 2006-11-27

Publications (1)

Publication Number Publication Date
ECSP099328A true ECSP099328A (es) 2009-06-30

Family

ID=39226772

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009328A ECSP099328A (es) 2006-11-27 2009-05-13 Análogos de pirazol

Country Status (32)

Country Link
US (1) US7772269B2 (es)
EP (1) EP2097407A1 (es)
JP (1) JP4469924B2 (es)
KR (1) KR20090074264A (es)
CN (1) CN101541790A (es)
AP (1) AP2009004849A0 (es)
AR (1) AR063924A1 (es)
AU (1) AU2007327004A1 (es)
BR (1) BRPI0718672A2 (es)
CA (1) CA2667566C (es)
CL (1) CL2007003403A1 (es)
CO (1) CO6180447A2 (es)
CR (1) CR10745A (es)
CU (1) CU23801B7 (es)
DO (1) DOP2009000121A (es)
EA (1) EA016588B1 (es)
EC (1) ECSP099328A (es)
GE (1) GEP20125386B (es)
GT (1) GT200700104A (es)
HN (1) HN2007000505A (es)
IL (1) IL198412A0 (es)
MA (1) MA30924B1 (es)
MX (1) MX2009005526A (es)
NO (1) NO20092413L (es)
NZ (1) NZ576376A (es)
PE (1) PE20081299A1 (es)
RS (1) RS20090211A (es)
TN (1) TN2009000205A1 (es)
TW (1) TW200831495A (es)
UA (1) UA92833C2 (es)
UY (1) UY30743A1 (es)
WO (1) WO2008065493A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918392A (zh) 2007-11-26 2010-12-15 辉瑞有限公司 作为5-lo抑制剂的吡唑衍生物
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden
WO2011137363A1 (en) * 2010-04-30 2011-11-03 Allergan, Inc. Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
US8759386B2 (en) * 2011-01-24 2014-06-24 Boehringer Ingelheim International Gmbh Pyrazole compounds as CRTH2 antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
PL175987B1 (pl) 1993-06-14 1999-03-31 Pfizer Nowe imidazolowe inhibitory lipoksygenazy
US5883106A (en) 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JP3400392B2 (ja) * 1994-10-18 2003-04-28 ファイザー製薬株式会社 ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
ES2152539T3 (es) 1995-09-18 2001-02-01 Pfizer Imidazoles inhibidores de la lipoxigenasa.
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
JP2001100686A (ja) * 1999-09-28 2001-04-13 Hitachi Kokusai Electric Inc 表示データ取込方法及び比較検査装置
JP2001100682A (ja) * 1999-09-28 2001-04-13 Sanyo Electric Co Ltd サインシステム

Also Published As

Publication number Publication date
US20080125474A1 (en) 2008-05-29
EA016588B1 (ru) 2012-06-29
UY30743A1 (es) 2008-07-03
CL2007003403A1 (es) 2008-07-04
DOP2009000121A (es) 2009-06-15
EA200970422A1 (ru) 2009-12-30
GEP20125386B (en) 2012-01-25
WO2008065493A1 (en) 2008-06-05
PE20081299A1 (es) 2008-09-17
CA2667566C (en) 2012-01-03
AR063924A1 (es) 2009-02-25
AP2009004849A0 (en) 2009-06-30
US7772269B2 (en) 2010-08-10
EP2097407A1 (en) 2009-09-09
CA2667566A1 (en) 2008-06-05
JP4469924B2 (ja) 2010-06-02
KR20090074264A (ko) 2009-07-06
BRPI0718672A2 (pt) 2013-11-26
AU2007327004A1 (en) 2008-06-05
MX2009005526A (es) 2009-06-05
GT200700104A (es) 2011-04-13
UA92833C2 (en) 2010-12-10
CR10745A (es) 2009-05-22
NZ576376A (en) 2011-02-25
TW200831495A (en) 2008-08-01
CU20090083A7 (es) 2011-09-21
HN2007000505A (es) 2010-06-09
TN2009000205A1 (fr) 2010-10-18
CN101541790A (zh) 2009-09-23
JP2010511601A (ja) 2010-04-15
MA30924B1 (fr) 2009-11-02
NO20092413L (no) 2009-07-20
RS20090211A (sr) 2010-10-31
CO6180447A2 (es) 2010-07-19
IL198412A0 (en) 2010-02-17
CU23801B7 (es) 2012-03-15

Similar Documents

Publication Publication Date Title
DOP2011000010A (es) Derivados de triazol utiles para el tratamiento de enfermedades
ECSP088717A (es) Derivados de amina
ECSP066701A (es) Derivados de sulfonamida para el tratamiento de enfermedades
CR10700A (es) Derivados de sulfonamida
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
CR11627A (es) Derivados heterociclicos fusionados y metodos de uso como inhibidores c-met
CR20120264A (es) Compuestos
PA8622001A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
CR11208A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
NI201500142A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos.
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
CU20090083A7 (es) Análogos de pirazol
CR8636A (es) Compuestos utiles para el tratamiento de enfermedades
CU20060180A7 (es) Derivados de formamida para el tratamiento de enfermedades
GT200500056A (es) Compuestos utiles para el tratamiento de enfermedades
DOP2005000045A (es) Derivados de formamida para el tratamiento de enfermedades
ECSP066832A (es) Compuestos para el tratamiento de enfermedades
CU20100014A7 (es) Derivados de pirimidina útiles para el tratamiento de enfermedades inflamatorias o alérgicas
CU23537B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades
CU23532B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades
DOP2005000043A (es) Compuestos para el tratamiento de enfermedades
DOP2005000037A (es) Compuestos utiles para el tratamiento de enfermedades
CU20110002A7 (es) Derivados de triazol útiles para el tratamiento de enfermedades
ECSP066871A (es) Derivados de formamida útiles como adrenoceptores
ECSP066854A (es) Compuestos utiles para el tratamiento de enfermedades